News

Public · Published

Bausch + Lomb Corporation (BLCO) Q3 Revenue Up 7% to $1.38B; Net Income $32M

Bausch + Lomb reported Q3 2026 revenue of $1.375B, up 7% from a year earlier. Net income was $32M, compared with a $28M loss a year earlier. Adjusted EBITDA, a profit measure that excludes certain items, rose to $325M from $243M.

Published:

Updated:

What happened

Bausch + Lomb reported Q3 2026 revenue of $1.375B, up 7% from a year earlier. Net income was $32M, compared with a $28M loss a year earlier. Adjusted EBITDA, a profit measure that excludes certain items, rose to $325M from $243M.

Confirmed

Global impact / market context

Returning to a profit and lifting adjusted EBITDA from $243M to $325M means the company keeps more cash from each sale after costs. That stronger cash generation can support debt repayment, spending on new products, and less reliance on accounting adjustments investors often discount.

Analyst inference

Every segment grew, with Vision Care and Pharma both expanding, which suggests demand is broad rather than tied to one product. Four quarters of meeting Investor Day commitments, which are public financial targets, may reduce execution doubt ahead of the planned separation.

Analyst inference

What to watch

  1. The article says a larger catalyst would be explicit guidance metrics, which are management's own forward financial targets, sustained double-digit growth in higher-profit segments, or updates on the planned separation timeline. Confirmed
  2. Investors could compare future quarterly revenue and adjusted EBITDA against these Q3 levels to judge whether growth and profit gains persist rather than reflect one strong period. Proposed
  3. Watch whether Pharma and Vision Care growth continue, since slower growth in these segments would weaken the cash flow supporting the planned separation and reduce the profit gains seen this quarter. Analyst inference

Evidence

  • Original source link unavailable